Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
kidney neoplasms/durchfall
Der Link wird in der Zwischenablage gespeichert
10 Ergebnisse
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a .sctn. 371 of International Application No. PCT/IB2015/056905, filed 9 Sep. 2015, which claims the priority of PCT/CN2015/086995, filed 14 Aug. 2015, and PCT/CN2014/086197, filed 10 Sep. 2014, which are incorporated herein in their entireties.
FIELD OF INVENTION
This invention
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a .sctn.371 of International Application No. PCT/CN2015/089332, filed 10 Sep. 2015, which claims the priority of PCT/CN2014/000834, filed 10 Sep. 2014, which are incorporated herein in their entireties.
FIELD OF INVENTION
This invention relates to novel compounds which are
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Pyridine derivatives as rearranged during transfection (RET) kinase inhibitors
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This application is a 371 of International Application No. PCT/IB2014/059817, filed 14 Mar. 2014, which claims priority of PCT/CN2014/072449, filed 24 Feb. 2014; PCT/CN2013/090059, filed 20 Dec. 2013; and PCT/CN2013/072683, filed 15 Mar. 2013.
FIELD OF INVENTION
This invention relates to novel
Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird
- Arbeitet in 55 Sprachen
- Von der Wissenschaft unterstützte Kräuterkuren
- Kräutererkennung durch Bild
- Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
- Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
- Suchen Sie nach Heilkräutern nach ihrer Wirkung
- Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden
Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen
